We examine, as model-independently as possible, the production of bileptons at hadron colliders. When a particular model is necessary or useful, we choose the 3-3-1 model. We consider a variety of processes:, where Y and φ are vector and scalar bileptons, respectively. Given the present low-energy constraints, we find that at the Tevatron, vector bileptons are unobservable, while light scalar bileptons (M φ < ∼ 300 GeV) are just barely observable. At the LHC, the reach is extended considerably: vector bileptons of mass M Y < ∼ 1 TeV are observable, as are scalar bileptons of mass M φ < ∼ 850 GeV.
We consider a geometrically motivated Skyrme model based on a general covariant kinetic term proposed originally by Born and Infeld. We introduce this new term by generalizing the Born-Infeld action to a non-abelian SU (2) gauge theory and by using the hidden gauge symmetry formalism. The static properties of the Skyrmion are then analyzed and compared with other Skyrme-like models.
GCA of the thoracic aorta may be suspected in less than 25% of patients preoperatively. Clinical presentation may be acute or chronic with localized or diffused aortic involvement but always involved the ascending aorta. Surgery may be performed with excellent outcomes. Follow-up imaging is mandatory to assess aortic progression.
We perform a simulation of scalar leptoquark pair production at the Tevatron ( √ s = 1.8 TeV and L = 100 pb −1 ) with ISAJET. We also investigate the dominant sources of Standard Model background: Z * jj, ZZ, W Z production and heavy quark tt. We find that the Z * jj background is dominant. We also evaluate the signal-to-background ratio and find a discovery reach of 130 GeV (170 GeV) for a branching ratio of BR(LQ → eq) = 0.5 (BR = 1).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.